Found 9 results
Author Title Type [ Year(Desc)]
Filters: Author is Depner, Christopher M  [Clear All Filters]
2012
C. M. Depner, Torres-Gonzalez, M., Tripathy, S., Milne, G., and Jump, D. B., “Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.”, The Journal of nutrition, vol. 142, no. 8, pp. 1495-503, 2012.
D. B. Jump, Depner, C. M., and Tripathy, S., “Omega-3 fatty acid supplementation and cardiovascular disease.”, Journal of lipid research, vol. 53, no. 12, pp. 2525-45, 2012.
2013
C. M. Depner, Philbrick, K. A., and Jump, D. B., “Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.”, J Nutr, vol. 143, no. 3, pp. 315-23, 2013.
D. B. Jump, Tripathy, S., and Depner, C. M., “Fatty acid-regulated transcription factors in the liver.”, Annu Rev Nutr, vol. 33, pp. 249-69, 2013.
C. M. Depner, Traber, M., Bobe, G., Kensicki, E., Bohren, K. M., Milne, G., and Jump, D. B., “A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.”, PLoS One, vol. 8, no. 12, p. e83756, 2013.
2015
K. A. Lytle, Depner, C. M., Wong, C. P., and Jump, D. B., “Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.”, J Lipid Res, vol. 56, no. 10, pp. 1936-46, 2015.
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., “Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.”, Advances in nutrition (Bethesda, Md.), vol. 6, no. 6, pp. 694-702, 2015.
2016
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., “Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.”, Proc Nutr Soc, vol. 75, no. 1, pp. 1-9, 2016.
2018
D. B. Jump, Lytle, K. A., Depner, C. M., and Tripathy, S., “Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.”, Pharmacol Ther, vol. 181, pp. 108-125, 2018.